Physician profile
Joseph Statz
NPI 1225444045
$23,657.24
in general payments reported to CMS, 2019-2025
15 companies · $27.61 in 2025
The $27.61 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,132 · 2020: $5,326 · 2021: $7,622 · 2022: $1,956 · 2023: $1,201 · 2024: $6,393 · 2025: $27.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,737 · Food and Beverage: $1,517 · Travel and Lodging: $367.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,737.15 |
| Food and Beverage | $1,517.13 |
| Travel and Lodging | $366.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $12,670.21 | 2019-2024 | Attune |
| Depuy Synthes Products, INC. | $5,384.60 | 2024 | Velys |
| Stryker Corporation | $2,225.62 | 2019-2023 | Accolade, Na |
| Smith+Nephew, INC. | $1,073.95 | 2020-2023 | Journey II |
| Depuy Synthes Sales INC. | $765.49 | 2020-2025 | Velys, Attune |
| Zimmer Biomet Holdings, INC. | $335.56 | 2022-2024 | Avitus Bone Harvester, Persona |
| Next Science LLC | $321.27 | 2021-2024 | Surgx, Xperience, Blastx |
| Medacta USA, INC. | $251.09 | 2019-2022 | |
| Bioventus LLC | $153.31 | 2021 | |
| Peerless Surgical INC. | $124.70 | 2020 | |
| Osteoremedies, LLC | $120.61 | 2023 | Remedy Spectrum Gv Spacer, Remedy Spacer |
| Medtronic USA, INC. | $108.50 | 2019 | |
| Davol INC. | $57.14 | 2021 | |
| Onkos Surgical, INC. | $41.21 | 2023 | Eleos Limb Salvage System |
| Orthalign INC | $23.98 | 2024 | Orthalign Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Statz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.